Community pharmacy type 2 diabetes risk assessment: demographics and risk results

Michael J. Twigg; David J. Wright; Tracey Thornley; Lisa Haynes

doi:10.1111/ijpp.12139

Community pharmacy type 2 diabetes risk assessment: demographics and risk results

Michael J. Twigg, David J. Wright, Tracey Thornley, Lisa Haynes

Patient Care

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

16 Downloads (Pure)

Abstract

Objectives:
To determine the demographics and risk results of patients accessing a community pharmacy diabetes risk assessment service.

Method:
Participating patients underwent an assessment using a validated questionnaire to determine their 10-year risk of developing type 2 diabetes. Patients were given appropriate lifestyle advice or referred to their general practitioner if necessary.

Key findings:
In total, 21 302 risk assessments were performed. Nearly one-third (29%) of 3427 risk assessments analysed yielded a result of moderate or high chance of developing the condition.

Conclusions:
Community pharmacies can identify a significant number of patients at risk of developing type 2 diabetes in the next 10 years. Further follow-up work needs to be done to determine the cost-effectiveness of such a service and the consequences of receiving a risk assessment.

Original language	English
Pages (from-to)	80-82
Number of pages	3
Journal	International Journal of Pharmacy Practice
Volume	23
Issue number	1
Early online date	22 Jul 2014
DOIs	https://doi.org/10.1111/ijpp.12139
Publication status	Published - Feb 2015

Keywords

community pharmacy
diabetes
diet
health promotion
risk assessment

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/ijpp.12139Licence: CC BY-NC-ND

IJPP final paperFinal published version, 183 KBLicence: CC BY-NC-ND

Cite this

@article{6b33bf71abb14491ab9966c554ec4f00,

title = "Community pharmacy type 2 diabetes risk assessment: demographics and risk results",

abstract = "Objectives: To determine the demographics and risk results of patients accessing a community pharmacy diabetes risk assessment service. Method: Participating patients underwent an assessment using a validated questionnaire to determine their 10-year risk of developing type 2 diabetes. Patients were given appropriate lifestyle advice or referred to their general practitioner if necessary.Key findings: In total, 21 302 risk assessments were performed. Nearly one-third (29%) of 3427 risk assessments analysed yielded a result of moderate or high chance of developing the condition.Conclusions: Community pharmacies can identify a significant number of patients at risk of developing type 2 diabetes in the next 10 years. Further follow-up work needs to be done to determine the cost-effectiveness of such a service and the consequences of receiving a risk assessment.",

keywords = "community pharmacy, diabetes, diet, health promotion, risk assessment",

author = "Twigg, {Michael J.} and Wright, {David J.} and Tracey Thornley and Lisa Haynes",

note = "{\textcopyright} 2014 The Authors. International Journal of Pharmacy Practice published by John Wiley & Sons Ltd on behalf of Royal Pharmaceutical Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. ",

year = "2015",

month = feb,

doi = "10.1111/ijpp.12139",

language = "English",

volume = "23",

pages = "80--82",

journal = "International Journal of Pharmacy Practice",

issn = "0961-7671",

publisher = "Pharmaceutical Press",

number = "1",

}

TY - JOUR

T1 - Community pharmacy type 2 diabetes risk assessment: demographics and risk results

AU - Twigg, Michael J.

AU - Wright, David J.

AU - Thornley, Tracey

AU - Haynes, Lisa

N1 - © 2014 The Authors. International Journal of Pharmacy Practice published by John Wiley & Sons Ltd on behalf of Royal Pharmaceutical Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PY - 2015/2

Y1 - 2015/2

N2 - Objectives: To determine the demographics and risk results of patients accessing a community pharmacy diabetes risk assessment service. Method: Participating patients underwent an assessment using a validated questionnaire to determine their 10-year risk of developing type 2 diabetes. Patients were given appropriate lifestyle advice or referred to their general practitioner if necessary.Key findings: In total, 21 302 risk assessments were performed. Nearly one-third (29%) of 3427 risk assessments analysed yielded a result of moderate or high chance of developing the condition.Conclusions: Community pharmacies can identify a significant number of patients at risk of developing type 2 diabetes in the next 10 years. Further follow-up work needs to be done to determine the cost-effectiveness of such a service and the consequences of receiving a risk assessment.

AB - Objectives: To determine the demographics and risk results of patients accessing a community pharmacy diabetes risk assessment service. Method: Participating patients underwent an assessment using a validated questionnaire to determine their 10-year risk of developing type 2 diabetes. Patients were given appropriate lifestyle advice or referred to their general practitioner if necessary.Key findings: In total, 21 302 risk assessments were performed. Nearly one-third (29%) of 3427 risk assessments analysed yielded a result of moderate or high chance of developing the condition.Conclusions: Community pharmacies can identify a significant number of patients at risk of developing type 2 diabetes in the next 10 years. Further follow-up work needs to be done to determine the cost-effectiveness of such a service and the consequences of receiving a risk assessment.

KW - community pharmacy

KW - diabetes

KW - diet

KW - health promotion

KW - risk assessment

U2 - 10.1111/ijpp.12139

DO - 10.1111/ijpp.12139

M3 - Article

VL - 23

SP - 80

EP - 82

JO - International Journal of Pharmacy Practice

JF - International Journal of Pharmacy Practice

SN - 0961-7671

IS - 1

ER -